Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-12-05T02:40:21.169Z Has data issue: false hasContentIssue false
  • English
  • Français

Other Recent Case Developments

Published online by Cambridge University Press:  29 April 2021

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Recent Developments in Law and Policy
Information
Law, Medicine and Healthcare , Volume 20 , Issue 3 , Fall 1992 , pp. 262 - 267
Copyright
© 1992 American Society of Law, Medicine & Ethics

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Health Care Programs: Fraud and Abuse; Amendments to OIG Exclusion and CMP Authorities Resulting from Public Law No. 100–93, 57 Fed. Reg. 3298 (1992) (to be codified at 42 C.F.R. §§ 1001–07). N.B.: This note is a brief overview of the new OIG regulation. Since many of the provisions have numerous exceptions, all concerned about this regulation should review the full text of the rule.Google Scholar
See Gostin, Larry O., “Genetic Discrimination: The Use of Genetically Based Diagnostic and Prognostic Tests by Employers and Insurers,” 17 Am. J. L. and Med. 109 (1991) for further information on genetic discrimination.Google Scholar